Boule Diagnostics, together with its Italian distribution partner A. Menarini Diagnostics, is proud to announce its selection as one of only three providers in a nationwide tender for hematology solutions in Italy. The tender decision, finalized on November 28, 2025, marks a significant milestone for Boule in the Italian market. Boule achieved the highest overall score based on quality and price, reinforcing its position as a trusted partner in diagnostic excellence. The tender covers an estimated total volume of 1,450 hematology instruments, representing a major opportunity to strengthen Boule’s presence in Italy. We believe this achievement will have a positive impact starting in 2026, supporting healthcare providers with advanced diagnostic solutions.

"We are honored to be recognized in Italy for both quality and value," said Torben Nielsen, CEO of Boule Diagnostics. "Being selected together with our Italian distribution partner, A. Menarini Diagnostics, reflects our shared commitment to excellence and our mission to make advanced hematology diagnostics accessible worldwide."

This selection ensures that Boule’s hematology systems will be available to healthcare facilities across Italy, contributing to improved diagnostic capabilities and better patient outcomes.